BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin AND Prognosis
10 results:

  • 1. [Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome].
    ; ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Sep; 46(9):897-908. PubMed ID: 37670643
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tuberous Sclerosis Complex: Genetic counselling and perinatal follow-up.
    Touraine R; Hauet Q; Harzallah I; Baruteau AE
    Arch Pediatr; 2022 Dec; 29(5S):5S3-5S7. PubMed ID: 36585068
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mutational Characteristics of Primary Mucosal Melanoma: A Systematic Review.
    Beaudoux O; Oudart JB; Riffaud L; Visseaux L; Marchal A; Lebre AS; Grange F
    Mol Diagn Ther; 2022 Mar; 26(2):189-202. PubMed ID: 35195858
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Tuberous sclerosis complex: analysis of areas of involvement, treatment progress and translation to routine clinical practice in a cohort of paediatric patients].
    Cantarín-Extremera V; Bernardino-Cuesta B; Martín-Villaescusa C; Melero-Llorente J; Hernández-Martín A; Aparicio-López C; de Lucas-Collantes C; Tamariz Martel-Moreno A; Duat-Rodríguez A; Ruiz-Falcó-Rojas ML
    Rev Neurol; 2021 Sep; 73(5):141-150. PubMed ID: 34328203
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Phenotypic distinctions between mosaic forms of tuberous sclerosis complex.
    Treichel AM; Hamieh L; Nathan NR; Tyburczy ME; Wang JA; Oyerinde O; Raiciulescu S; Julien-Williams P; Jones AM; Gopalakrishnan V; Moss J; Kwiatkowski DJ; Darling TN
    Genet Med; 2019 Nov; 21(11):2594-2604. PubMed ID: 31114024
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rhabdomyomas and tuberous sclerosis complex: our experience in 33 cases.
    Sciacca P; Giacchi V; Mattia C; Greco F; Smilari P; Betta P; Distefano G
    BMC Cardiovasc Disord; 2014 May; 14():66. PubMed ID: 24884933
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of tsc2.
    Lopez-Rivera E; Jayaraman P; Parikh F; Davies MA; Ekmekcioglu S; Izadmehr S; Milton DR; Chipuk JE; Grimm EA; Estrada Y; Aguirre-Ghiso J; Sikora AG
    Cancer Res; 2014 Feb; 74(4):1067-78. PubMed ID: 24398473
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Coexistence of tuberous sclerosis complex and malignant melanoma.
    Günaldi M; Paydas S; Afsar CU; Doran F
    Singapore Med J; 2013 Nov; 54(11):e233-5. PubMed ID: 24276112
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Melanoma, nevogenesis, and stem cell biology.
    Grichnik JM
    J Invest Dermatol; 2008 Oct; 128(10):2365-80. PubMed ID: 18787546
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Lymphangioleiomyomatosis and tuberous sclerosis.
    Hancock E; Tomkins S; Sampson J; Osborne J
    Respir Med; 2002 Jan; 96(1):7-13. PubMed ID: 11863212
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.